Two PPARγ activators PGJ2 and pioglitazone were reported to induce apoptosis by decreasing Bcl-2 in chronic hepatitis B-associated hepatocellular carcinoma cells [52]. The gene discussed is BCL2; the disease is hepatocellular carcinoma.